NCT01849289View on ClinicalTrials.gov

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

833

Participants

Timeline

Start Date

June 2, 2013

Primary Completion Date

May 15, 2014

Study Completion Date

May 15, 2014

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

Insulin Degludec

Administered subcutaneously (under the skin), dose individually adjusted, once daily in combination with metformin at the unchanged, stable, pre-randomisation dose level and dosing frequency.

DRUG

Insulin Glargine

Administered subcutaneously (under the skin), dose individually adjusted, once daily in combination with metformin at the unchanged, stable, pre-randomisation dose level and dosing frequency.

Trial Locations (81)

1812

Novo Nordisk Investigational Site, Johannesburg

2193

Novo Nordisk Investigational Site, Johannesburg

4001

Novo Nordisk Investigational Site, Durban

4091

Novo Nordisk Investigational Site, Durban

6529

Novo Nordisk Investigational Site, George

11787

Novo Nordisk Investigational Site, Smithtown

21010

Novo Nordisk Investigational Site, Vinnitsa

23606

Novo Nordisk Investigational Site, Newport News

29681

Novo Nordisk Investigational Site, Simpsonville

33765

Novo Nordisk Investigational Site, Clearwater

38305

Novo Nordisk Investigational Site, Jackson

48098

Novo Nordisk Investigational Site, Troy

49005

Novo Nordisk Investigational Site, Dnipro

49038

Novo Nordisk Investigational Site, Dnipro

53142

Novo Nordisk Investigational Site, Kenosha

54003

Novo Nordisk Investigational Site, Mykolaiv

60607

Novo Nordisk Investigational Site, Chicago

63017

Novo Nordisk Investigational Site, Chesterfield

70002

Novo Nordisk Investigational Site, Metairie

75230

Novo Nordisk Investigational Site, Dallas

80401

Novo Nordisk Investigational Site, Golden

90057

Novo Nordisk Investigational Site, Los Angeles

90717

Novo Nordisk Investigational Site, Lomita

92801

Novo Nordisk Investigational Site, Anaheim

100029

Novo Nordisk Investigational Site, Beijing

100039

Novo Nordisk Investigational Site, Beijing

100191

Novo Nordisk Investigational Site, Beijing

100700

Novo Nordisk Investigational Site, Beijing

100730

Novo Nordisk Investigational Site, Beijing

100853

Novo Nordisk Investigational Site, Beijing

110004

Novo Nordisk Investigational Site, Shenyang

110021

Novo Nordisk Investigational Site, Shenyang

120203

Novo Nordisk Investigational Site, Buzău

130041

Novo Nordisk Investigational Site, Changchun

136000

Novo Nordisk Investigational Site, Siping

150086

Novo Nordisk Investigational Site, Harbin

200040

Novo Nordisk Investigational Site, Shanghai

200072

Novo Nordisk Investigational Site, Shanghai

212001

Novo Nordisk Investigational Site, Zhenjiang

225001

Novo Nordisk Investigational Site, Yangzhou

230001

Novo Nordisk Investigational Site, Hefei

310003

Novo Nordisk Investigational Site, Hangzhou

325000

Novo Nordisk Investigational Site, Wenzhou

330006

Novo Nordisk Investigational Site, Nanchang

350025

Novo Nordisk Investigational Site, Fuzhou

400010

Novo Nordisk Investigational Site, Chongqing

400016

Novo Nordisk Investigational Site, Chongqing

404000

Novo Nordisk Investigational Site, Chongqing

410469

Novo Nordisk Investigational Site, Oradea

414000

Novo Nordisk Investigational Site, Yueyang

430030

Novo Nordisk Investigational Site, Wuhan

430034

Novo Nordisk Investigational Site, Wuhan

510120

Novo Nordisk Investigational Site, Guangzhou

530007

Novo Nordisk Investigational Site, Nanning

550004

Novo Nordisk Investigational Site, Guiyang

550176

Novo Nordisk Investigational Site, Sibiu

650101

Novo Nordisk Investigational Site, Kunming

710032

Novo Nordisk Investigational Site, Xi'an

800578

Novo Nordisk Investigational Site, Galati

41017-3464

Novo Nordisk Investigational Site, Crestview Hills

03063

Novo Nordisk Investigational Site, Nashua

08755-8050

Novo Nordisk Investigational Site, Toms River

01244-030

Novo Nordisk Investigational Site, São Paulo

90035-170

Novo Nordisk Investigational Site, Porto Alegre

04022-002

Novo Nordisk Investigational Site, São Paulo

T2N 4L7

Novo Nordisk Investigational Site, Calgary

V5G 1T4

Novo Nordisk Investigational Site, Burnaby

V3S 2N6

Novo Nordisk Investigational Site, Surrey

V8V 4A1

Novo Nordisk Investigational Site, Victoria

L7M 4Y1

Novo Nordisk Investigational Site, Burlington

N5W 6A2

Novo Nordisk Investigational Site, London

N6P 1A9

Novo Nordisk Investigational Site, London

L3Y 5G8

Novo Nordisk Investigational Site, Newmarket

N7T 4X3

Novo Nordisk Investigational Site, Sarnia

N7G 1Y7

Novo Nordisk Investigational Site, Strathroy

G3K 2P8

Novo Nordisk Investigational Site, Québec

G8T7A1

Novo Nordisk Investigational Site, Trois-Rivières

050051

Novo Nordisk Investigational Site, Shijiazhuang

050082

Novo Nordisk Investigational Site, Shijiazhuang

020614

Novo Nordisk Investigational Site, Bucharest

04114

Novo Nordisk Investigational Site, Kiev

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01849289 - A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter